{"DataElement":{"publicId":"5990051","version":"1","preferredName":"Prostate Cancer AJCC Edition 8 Pathologic Tumor T Category","preferredDefinition":"Extent of the primary prostate carcinoma based on clinical stage information combined with operative findings, and evidence obtained from pathology review when surgery is the first definitive therapy, using AJCC Ed. 8 criteria.","longName":"PROS_AJC8_PTH_T_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"2188818","version":"1","preferredName":"Prostate Tumor Pathologic T Stage","preferredDefinition":"Information related to pathologic T stage for prostate tumor.","longName":"PRS_TUMOR_P_T","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206573","version":"1","preferredName":"Prostate Neoplasm","preferredDefinition":"A gland in the male reproductive system just below the bladder. It surrounds part of the urethra, the canal that empties the bladder. It produces a fluid that forms part of semen. (NCI-GLOSS):(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12410:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Gland","conceptCode":"C12410","definition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FA7A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207099","version":"1","preferredName":"Pathologic T Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25610:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-1838-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E56816DF-3F94-5257-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-01","modifiedBy":"TAYLORT","dateModified":"2017-09-13","changeDescription":"9/13/17 tt transferred context; changed def - 1st letter upper case; changed Reg Status to Qualified.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6032124","version":"1","preferredName":"Prostate Carcinoma American Joint Committee on Cancer Edition 8 Pathologic T Category","preferredDefinition":"A pathologic finding about one or more characteristics of prostate cancer, following the rules of the TNM AJCC v8 classification system as they pertain to staging of the primary tumor. There is no pathologic T1 classification._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion)._A grouping of items based on some commonality or by user defined characteristics.","longName":"6032124v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T4","valueDescription":"Prostate Cancer pT4 TNM Finding v8","ValueMeaning":{"publicId":"6032126","version":"1","preferredName":"Prostate Cancer pT4 TNM Finding v8","longName":"6032126","preferredDefinition":"Prostate cancer in which the tumor is fixed or invades adjacent structures other than seminal vesicles such as external sphincter, rectum, bladder, levator muscles, and/or pelvic wall. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer pT4 TNM Finding v8","conceptCode":"C140156","definition":"Prostate cancer in which the tumor is fixed or invades adjacent structures other than seminal vesicles such as external sphincter, rectum, bladder, levator muscles, and/or pelvic wall. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E926449-F6F9-6B4F-E053-F662850AD717","latestVersionIndicator":"Yes","beginDate":"2017-11-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E926449-F712-6B4F-E053-F662850AD717","beginDate":"2017-11-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-22","modifiedBy":"ONEDATA","dateModified":"2017-11-22","deletedIndicator":"No"},{"value":"T3b","valueDescription":"Prostate Cancer pT3b TNM Finding v8","ValueMeaning":{"publicId":"6032128","version":"1","preferredName":"Prostate Cancer pT3b TNM Finding v8","longName":"6032128","preferredDefinition":"Prostate cancer with tumor invading seminal vesicle(s). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer pT3b TNM Finding v8","conceptCode":"C140155","definition":"Prostate cancer with tumor invading seminal vesicle(s). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E926449-F71F-6B4F-E053-F662850AD717","latestVersionIndicator":"Yes","beginDate":"2017-11-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E926449-F738-6B4F-E053-F662850AD717","beginDate":"2017-11-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-22","modifiedBy":"ONEDATA","dateModified":"2017-11-22","deletedIndicator":"No"},{"value":"T3a","valueDescription":"Prostate Cancer pT3a TNM Finding v8","ValueMeaning":{"publicId":"6032130","version":"1","preferredName":"Prostate Cancer pT3a TNM Finding v8","longName":"6032130","preferredDefinition":"Prostate cancer with extraprostatic extension (unilateral or bilateral) or microscopic invasion of bladder neck. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer pT3a TNM Finding v8","conceptCode":"C140154","definition":"Prostate cancer with extraprostatic extension (unilateral or bilateral) or microscopic invasion of bladder neck. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E926449-F745-6B4F-E053-F662850AD717","latestVersionIndicator":"Yes","beginDate":"2017-11-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E926449-F75E-6B4F-E053-F662850AD717","beginDate":"2017-11-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-22","modifiedBy":"ONEDATA","dateModified":"2017-11-22","deletedIndicator":"No"},{"value":"T3","valueDescription":"Prostate Cancer pT3 TNM Finding v8","ValueMeaning":{"publicId":"6032132","version":"1","preferredName":"Prostate Cancer pT3 TNM Finding v8","longName":"6032132","preferredDefinition":"Prostate cancer with extraprostatic extension. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer pT3 TNM Finding v8","conceptCode":"C140153","definition":"Prostate cancer with extraprostatic extension. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E926449-F76B-6B4F-E053-F662850AD717","latestVersionIndicator":"Yes","beginDate":"2017-11-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E926449-F784-6B4F-E053-F662850AD717","beginDate":"2017-11-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-22","modifiedBy":"ONEDATA","dateModified":"2017-11-22","deletedIndicator":"No"},{"value":"T2","valueDescription":"Prostate Cancer pT2 TNM Finding v8","ValueMeaning":{"publicId":"6032134","version":"1","preferredName":"Prostate Cancer pT2 TNM Finding v8","longName":"6032134","preferredDefinition":"Prostate cancer which is organ confined. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer pT2 TNM Finding v8","conceptCode":"C140152","definition":"Prostate cancer which is organ confined. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E926449-F791-6B4F-E053-F662850AD717","latestVersionIndicator":"Yes","beginDate":"2017-11-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E926449-F7AA-6B4F-E053-F662850AD717","beginDate":"2017-11-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-22","modifiedBy":"ONEDATA","dateModified":"2017-11-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6059346","version":"1","preferredName":"Prostate Cancer Pathologic Primary Tumor TNM Finding v8 American Joint Committee on Cancer T Category Category","preferredDefinition":"A pathologic finding about one or more characteristics of prostate cancer, following the rules of the TNM AJCC v8 classification system as they pertain to staging of the primary tumor. There is no pathologic T1 classification.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:A grouping of items based on some commonality or by user defined characteristics.","longName":"C140151:C39315:C25728:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer Pathologic Primary Tumor TNM Finding v8","conceptCode":"C140151","definition":"A pathologic finding about one or more characteristics of prostate cancer, following the rules of the TNM AJCC v8 classification system as they pertain to staging of the primary tumor. There is no pathologic T1 classification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"63FFE168-5E2E-160C-E053-F662850A931D","latestVersionIndicator":"Yes","beginDate":"2018-01-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-30","modifiedBy":"ONEDATA","dateModified":"2018-01-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"5E926449-F6DD-6B4F-E053-F662850AD717","latestVersionIndicator":"Yes","beginDate":"2017-11-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-22","modifiedBy":"TAYLORT","dateModified":"2019-09-04","changeDescription":"4/9/18 tt released. 11/22/17 tt created for standardization, associated with CS/CSI; supercedes 3436530.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5506113","version":"1","longName":"Prostate","context":"MCL","ClassificationSchemeItems":[{"publicId":"7781145","version":"1","longName":"Prostate PCA Pilot","context":"MCL"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"10000015","version":"1","longName":"Prostate","context":"NCI Standards"}]},{"publicId":"6437797","version":"1","longName":"Pre-Cancer Atlas Pilot","context":"MCL","ClassificationSchemeItems":[{"publicId":"7001794","version":"1","longName":"Prostate PCA Pilot","context":"MCL"}]},{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"5635376","version":"1","longName":"Prostate","context":"OCCPR"},{"publicId":"6779561","version":"1","longName":"PRAD Baseline","context":"OCCPR"}]}],"AlternateNames":[{"name":"MCL","type":"USED_BY","context":"MCL"},{"name":"OCCPR","type":"USED_BY","context":"OCCPR"},{"name":"ajcc_8_prostate_pathologic_t","type":"MCL Alt Name","context":"MCL"}],"ReferenceDocuments":[{"name":"Pathologic T category","type":"Preferred Question Text","description":"Pathologic T category","url":null,"context":"NCI Standards"},{"name":"CPTAC-BSLN-1","type":"Alternate Question Text","description":"Pathologic Primary Tumor Status (pT)","url":null,"context":"OCCPR"},{"name":"MCL-PCA-prostate-1","type":"Alternate Question Text","description":"American Joint Committee on Cancer tumor stage code","url":null,"context":"MCL"},{"name":"MCL-Template Name","type":"Data Collection Template","description":"prostate_v0_13aug2020.xlsx","url":"https://mcl.nci.nih.gov/resources/standards/mcl-cdes","context":"MCL"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"5AE5D6B5-9AB3-68E2-E053-F662850A04C9","latestVersionIndicator":"Yes","beginDate":"2017-10-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-06","modifiedBy":"COLBERTM","dateModified":"2021-09-30","changeDescription":"9/30/21 mr Added alt name, AQT, alt def, ref doc, CSI per MCL prostate DD.   4/9/18 tt released. 11/22/17 tt associated with VD and CS/CSI. 10/6/17 tt Created for standard harmonization. Incomplete pending updates to VD per NCIt Ed 8 caDSR concept loading; supercedes CDE 3436563.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}